Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07607860 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Evaluation of the Adaptilens Accommodating IOL

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 56 words
    • Secondary endpoints: 2 to 1
    v3
  2. Eligibility criteria shortened, about 15 words
    • Secondary endpoints revised (2)
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goals of this feasibility study are to learn more about the performance of the intraocular lens (IOL), if the IOL is safe for use, and what the best surgical techniques are for implanting the IOL in patients who require correction of aphakia following phacoemulsification extraction of a senile cataract.
Trial Details
NCT Number NCT07607860
Lead Sponsor Adaptilens, Inc.
Conditions
(from sponsor)		 Aphakia Cataract
Related terms Cataract
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov